Michael Barbella, Managing Editor04.19.22
Minnetronix Medical and INO Innovation Center are teaming up to innovate and accelerate bringing optical medical devices to market.
The new partnership expands Minnetronix’ optics business and INO’s reach into the United States. INO has implemented more than 6,500 solutions, carried out 75 technology transfers, and contributed to the creation of 35 new companies.
The new collaboration has already completed its first successful project: INO developed a smart illumination system when no other commercial solutions were available, while Minnetronix led the complex system integration, including the proprietary illumination system, to deliver the final product to the customer.
“With more than 50 years of leading expertise in optics between INO and Minnetronix, our combined strengths will play a significant role in advancing our customers’ optics-based medical devices to the market. said Louis Martel, Vice President Business Development and Partnership at INO.
The partnership can also manage projects that require optical subsystems with larger, complex medical device systems; have complicated or diverse supply chains and/or require regulatory insights to scope design considerations relative to the U.S. Food and Drug Administration pathway.
Working with the Minnetronix-INO team, medical device companies gain access to deep expertise in optics and photonics and a seamless solution for bringing highly integrated optical medical devices from concept through commercial production.
Minnetronix’ suite of services is unique in the medical device industry because it includes full lifecycle support across medical device design, development, supply chain, and manufacturing. INO is a global leader in the optics field with the ability to control light to capture, identify, predict, and transform data into valuable and actionable information through multiple light applications—from laser and fiber optic technologies to imaging systems.
“There is increased complexity in creating optical medical devices, which this partnership solves,” said Matt Adams, vice president and general manager at Minnetronix. “For example, the supply chain for complex medical optics is often fragmented requiring customers to find specialized expertise in multiple small firms. Now, customers get the best brains in the industry under one umbrella to get their products to market faster.” Adams added that combining this joint expertise with a simple onboarding and project management process allows customers to seamlessly engage the team as a “one-stop shop” for optic and photonic projects.
INO brings to life innovations that enable the industry to be more productive and competitive. It is the largest center of expertise in optics and photonics in Canada and is among the best technological innovation centers in the world. For the past 30 years, it has created and developed solutions to meet the needs of businesses in Canada, North America, and the rest of the world with a team of more than 150 experts in optics and photonics. INO’s BioMedTech industry focuses, but is not limited to, point of care, decentralized medicine, wearables, remote monitoring, surgical navigation, quality control and inspection, optical sterilization/sanitizing, and advanced imaging technologies. ISO 13485 certified, INO specializes in the development of custom solutions from medical device design to prototyping and manufacturing. INO’s activities are made possible by sustained collaborations with the Ministère de I’Économie et de I’Innovation and the Canada Economic Development for Quebec Regions.
Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development, and manufacturing partner to global device companies. Today, through lifecycle efficiency, opportunity realization, and increased utility, the company creates value in key technology segments that include RF energy, fluid and gas management, optical systems, and stimulation and active wearables.
The new partnership expands Minnetronix’ optics business and INO’s reach into the United States. INO has implemented more than 6,500 solutions, carried out 75 technology transfers, and contributed to the creation of 35 new companies.
The new collaboration has already completed its first successful project: INO developed a smart illumination system when no other commercial solutions were available, while Minnetronix led the complex system integration, including the proprietary illumination system, to deliver the final product to the customer.
“With more than 50 years of leading expertise in optics between INO and Minnetronix, our combined strengths will play a significant role in advancing our customers’ optics-based medical devices to the market. said Louis Martel, Vice President Business Development and Partnership at INO.
The partnership can also manage projects that require optical subsystems with larger, complex medical device systems; have complicated or diverse supply chains and/or require regulatory insights to scope design considerations relative to the U.S. Food and Drug Administration pathway.
Working with the Minnetronix-INO team, medical device companies gain access to deep expertise in optics and photonics and a seamless solution for bringing highly integrated optical medical devices from concept through commercial production.
Minnetronix’ suite of services is unique in the medical device industry because it includes full lifecycle support across medical device design, development, supply chain, and manufacturing. INO is a global leader in the optics field with the ability to control light to capture, identify, predict, and transform data into valuable and actionable information through multiple light applications—from laser and fiber optic technologies to imaging systems.
“There is increased complexity in creating optical medical devices, which this partnership solves,” said Matt Adams, vice president and general manager at Minnetronix. “For example, the supply chain for complex medical optics is often fragmented requiring customers to find specialized expertise in multiple small firms. Now, customers get the best brains in the industry under one umbrella to get their products to market faster.” Adams added that combining this joint expertise with a simple onboarding and project management process allows customers to seamlessly engage the team as a “one-stop shop” for optic and photonic projects.
INO brings to life innovations that enable the industry to be more productive and competitive. It is the largest center of expertise in optics and photonics in Canada and is among the best technological innovation centers in the world. For the past 30 years, it has created and developed solutions to meet the needs of businesses in Canada, North America, and the rest of the world with a team of more than 150 experts in optics and photonics. INO’s BioMedTech industry focuses, but is not limited to, point of care, decentralized medicine, wearables, remote monitoring, surgical navigation, quality control and inspection, optical sterilization/sanitizing, and advanced imaging technologies. ISO 13485 certified, INO specializes in the development of custom solutions from medical device design to prototyping and manufacturing. INO’s activities are made possible by sustained collaborations with the Ministère de I’Économie et de I’Innovation and the Canada Economic Development for Quebec Regions.
Since 1996, Minnetronix Medical has accelerated medical device breakthroughs as a design, development, and manufacturing partner to global device companies. Today, through lifecycle efficiency, opportunity realization, and increased utility, the company creates value in key technology segments that include RF energy, fluid and gas management, optical systems, and stimulation and active wearables.